Cardiomyopathy
![BridgeBio Reports Improved Data for ATTR Cardiomyopathy Drug](https://pharmtales.com/wp-content/uploads/2023/07/BridgeBio-improves-on-data-for-ATTR-cardiomyopathy.jpg)
BridgeBio Reports Improved Data for ATTR Cardiomyopathy Drug
SG Tylor
Source – BridgeBio BridgeBio is preparing to seek FDA approval for its acoramidis drug to treat transthyretin amyloidosis (ATTR) cardiomyopathy, ...
Source – BridgeBio BridgeBio is preparing to seek FDA approval for its acoramidis drug to treat transthyretin amyloidosis (ATTR) cardiomyopathy, ...